Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

PPARβ/δ activation induces enteroendocrine L cell GLP-1 production.

Daoudi M, Hennuyer N, Borland MG, Touche V, Duhem C, Gross B, Caiazzo R, Kerr-Conte J, Pattou F, Peters JM, Staels B, Lestavel S.

Gastroenterology. 2011 May;140(5):1564-74. doi: 10.1053/j.gastro.2011.01.045. Epub 2011 Feb 4.

PMID:
21300064
2.

Epac is involved in cAMP-stimulated proglucagon expression and hormone production but not hormone secretion in pancreatic alpha- and intestinal L-cell lines.

Islam D, Zhang N, Wang P, Li H, Brubaker PL, Gaisano HY, Wang Q, Jin T.

Am J Physiol Endocrinol Metab. 2009 Jan;296(1):E174-81. doi: 10.1152/ajpendo.90419.2008. Epub 2008 Oct 14.

3.
4.

Peroxisome proliferator-activated receptor β/δ agonism protects the kidney against ischemia/reperfusion injury in diabetic rats.

Collino M, Benetti E, Miglio G, Castiglia S, Rosa AC, Aragno M, Thiemermann C, Fantozzi R.

Free Radic Biol Med. 2011 Jan 15;50(2):345-53. doi: 10.1016/j.freeradbiomed.2010.10.710. Epub 2010 Nov 1.

PMID:
21047550
5.

GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell.

Lauffer LM, Iakoubov R, Brubaker PL.

Diabetes. 2009 May;58(5):1058-66. doi: 10.2337/db08-1237. Epub 2009 Feb 10.

6.

Improving function and survival of pancreatic islets by endogenous production of glucagon-like peptide 1 (GLP-1).

Wideman RD, Yu IL, Webber TD, Verchere CB, Johnson JD, Cheung AT, Kieffer TJ.

Proc Natl Acad Sci U S A. 2006 Sep 5;103(36):13468-73. Epub 2006 Aug 28.

7.

Huang-lian-jie-du-decoction modulates glucagon-like peptide-1 secretion in diabetic rats.

Yu YL, Lu SS, Yu S, Liu YC, Wang P, Xie L, Wang GJ, Liu XD.

J Ethnopharmacol. 2009 Jul 30;124(3):444-9. doi: 10.1016/j.jep.2009.05.027. Epub 2009 Jun 2.

PMID:
19497359
8.

Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.

Theodorakis MJ, Carlson O, Michopoulos S, Doyle ME, Juhaszova M, Petraki K, Egan JM.

Am J Physiol Endocrinol Metab. 2006 Mar;290(3):E550-9. Epub 2005 Oct 11.

9.

Duodenal-jejunal bypass protects GK rats from {beta}-cell loss and aggravation of hyperglycemia and increases enteroendocrine cells coexpressing GIP and GLP-1.

Speck M, Cho YM, Asadi A, Rubino F, Kieffer TJ.

Am J Physiol Endocrinol Metab. 2011 May;300(5):E923-32. doi: 10.1152/ajpendo.00422.2010. Epub 2011 Feb 8.

10.

Glucocorticoids decrease the production of glucagon-like peptide-1 at the transcriptional level in intestinal L-cells.

Sato T, Hayashi H, Hiratsuka M, Hirasawa N.

Mol Cell Endocrinol. 2015 May 5;406:60-7. doi: 10.1016/j.mce.2015.02.014. Epub 2015 Feb 17.

PMID:
25700603
11.

Incretin hormone expression in the gut of diabetic mice and rats.

Berghöfer P, Peterson RG, Schneider K, Fehmann HC, Göke B.

Metabolism. 1997 Mar;46(3):261-7.

PMID:
9054467
12.

Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse.

Bahrami J, Longuet C, Baggio LL, Li K, Drucker DJ.

Gastroenterology. 2010 Sep;139(3):857-68. doi: 10.1053/j.gastro.2010.05.006. Epub 2010 Jun 11.

PMID:
20546737
13.

Intestinal mTOR regulates GLP-1 production in mouse L cells.

Xu G, Li Z, Ding L, Tang H, Guo S, Liang H, Wang H, Zhang W.

Diabetologia. 2015 Aug;58(8):1887-97. doi: 10.1007/s00125-015-3632-6. Epub 2015 Jun 3.

PMID:
26037201
14.

Adenoviral vector-mediated glucagon-like peptide 1 gene therapy improves glucose homeostasis in Zucker diabetic fatty rats.

Lee Y, Kwon MK, Kang ES, Park YM, Choi SH, Ahn CW, Kim KS, Park CW, Cha BS, Kim SW, Sung JK, Lee EJ, Lee HC.

J Gene Med. 2008 Mar;10(3):260-8.

PMID:
18085721
15.

Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.

Moulin D, Bianchi A, Boyault S, Sebillaud S, Koufany M, Francois M, Netter P, Jouzeau JY, Terlain B.

Arthritis Rheum. 2005 Mar;52(3):759-69.

16.

Glucagon-like peptide-1 gene therapy in obese diabetic mice results in long-term cure of diabetes by improving insulin sensitivity and reducing hepatic gluconeogenesis.

Lee YS, Shin S, Shigihara T, Hahm E, Liu MJ, Han J, Yoon JW, Jun HS.

Diabetes. 2007 Jun;56(6):1671-9. Epub 2007 Mar 16.

17.

Peptones stimulate both the secretion of the incretin hormone glucagon-like peptide 1 and the transcription of the proglucagon gene.

Cordier-Bussat M, Bernard C, Levenez F, Klages N, Laser-Ritz B, Philippe J, Chayvialle JA, Cuber JC.

Diabetes. 1998 Jul;47(7):1038-45.

PMID:
9648826
18.

Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells.

Trabelsi MS, Daoudi M, Prawitt J, Ducastel S, Touche V, Sayin SI, Perino A, Brighton CA, Sebti Y, Kluza J, Briand O, Dehondt H, Vallez E, Dorchies E, Baud G, Spinelli V, Hennuyer N, Caron S, Bantubungi K, Caiazzo R, Reimann F, Marchetti P, Lefebvre P, Bäckhed F, Gribble FM, Schoonjans K, Pattou F, Tailleux A, Staels B, Lestavel S.

Nat Commun. 2015 Jul 2;6:7629. doi: 10.1038/ncomms8629.

19.

Harnessing the therapeutic potential of glucagon-like peptide-1: a critical review.

Baggio LL, Drucker DJ.

Treat Endocrinol. 2002;1(2):117-25. Review.

PMID:
15765627
20.

Supplemental Content

Support Center